NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Therapeutics Technologies

Research Reports in Development.  The Virus Project has begun research on summarizing the 73 antiviral therapies in phase 2 or greater. This list includes:

  • 4D Pharma
  • AbbVie
  • Acer Therapeutics
  • Alexion Pharmaceuticals
  • Ansun Biopharma
  • Applied Therapeutics
  • ARMS Pharmaceutical
  • AstraZeneca
  • Atea Pharmaceuticals
  • Athersys
  • aTyr Pharma
  • Bausch Health
  • BerGenBio; ACCORD study
  • Beth Israel Deaconess
  • Biohaven Pharmaceuticals, Inc.
  • Blade Therapeutics
  • CalciMedica
  • Capricor Inc.
  • Celltex
  • Celularity
  • Chimerix
  • CTI Biopharma
  • CytoDyn
  • Eiger Biopharmaceuticals
  • Eli Lilly
  • Eli Lily/ Incyte
  • Ensysce Biosciences
  • Evelo Biosciences
  • Exvastat Ltd/ Global sponsors
  • Ferring Pharmaceuticals Inc.
  • FUJIFILM Toyama Chemical Co
  • Gilead
  • GSK
  • Hope Biosciences
  • Humanigen
  • I-Mab Biopharma
  • Immunic, Inc.
  • Implicit Bioscience
  • InflaRx N.V.
  • Insmed Inc.
  • Johnson & Johnson
  • Lattice Biologics
  • Laurent Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Mateon Therapeutics
  • Merck & Co., Inc
  • Mesoblast
  • NeuroRx
  • Novartis / Incyte
  • Novartis; other research sponsors
  • OctaPharma
  • OncoImmune
  • Ono Pharmaceutical Co., Ltd.
  • Partner Therapeutics (PTx)
  • Pfizer Inc.
  • Pharming
  • Pulmotect, Inc.
  • RedHill Biopharma
  • Regeneron
  • Ridgeback Biotherapeutics
  • Roche
  • Roivant Sciences
  • Romark Laboratories
  • Sanofi
  • Swedish Orphan Biovitrum
  • Synairgen
  • Takeda Pharmaceutical
  • Vanda Pharmaceuticals
  • Washington University School of Medicine
  • Yamanouchi Pharmaceutical Co.
  • ZymoGenetics, Inc